SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

Don't Let Winter Weather Slow Your Patients or Profits

Warm Up Your Practice With a Free Week of CloudVisit Connect for Safe, Easy Online Patient Care

COLD SPRING, NY -- (Marketwired) -- 01/16/14 -- As the temperature drops, patient needs tend to climb. Whether for colds and flu or mental health support, patients often need their healthcare providers when weather conditions make it most difficult to see them. To help close the gap between patient demand and practice opportunity, CloudVisit Telemedicine is offering a free, no-obligation trial of their HIPAA-compliant telemedicine and telepsychiatry platform, CloudVisit Connect.

CloudVisit Connect is the contract-free telemedicine software platform designed to make online patient care easy and affordable. Through pre-scheduled video appointments, providers and patients can see each other face-to-face without braving freezing temps or icy roads. Now through February 15th, CloudVisit Connect invites healthcare providers to try one free week of CloudVisit Connect.

Try CloudVisit Connect for free telemedicine and telepsychiatry

With the option to cancel at anytime, CloudVisit hopes providers will use this risk-free trial to connect with their patients online during these tough-to-travel months. Doctors and patients can each log in from home, eliminating the need for dangerous travel and exposure to waiting room germs.

"This time of year, telemedicine can actually be safer than in-office appointments, if you choose a HIPAA-compliant platform like CloudVisit," said Daniel Gilbert, president and CEO of CloudVisit Telemedicine. "Patients love the option to see their doctor online. Appointments increase, cancellations drop, and, most important, patients receive the care they need."

In just days, CloudVisit will have your practice up and running for web-based patient care. The simple online registration process results in secure access for you and your patients to schedule appointments and conduct real-time video sessions. Providers receive easy calendar management and reporting tools, plus automatic patient credit card billing.

"CloudVisit Connect fills a very definite void in telemedicine and telepsychiatry. It's safe, affordable, and easy," said Gilbert. "The service is very simple for providers and patients, regardless of how technically savvy they are."

The house call is back, no matter the weather

After the one-week free trial, providers can choose to continue seeing patients through their CloudVisit Connect website for only $175.00 per month. The telemedicine and telepsychiatry platform remains contract free with no limits on the number of patients or sessions. CloudVisit stands by the complete autonomy of their providers.

"We're not like other networks that lump doctors together, we're a powerful tool designed to make practices even more successful," clarified Gilbert. "Each provider is an independent practice with complete control over scheduling, session fees, and patients."

For more than a year, doctors, psychiatrists, psychologists, nurse practitioners, and other mental health professionals have trusted CloudVisit with their telepsychiatry and telemedicine practices. Get started with one free week of CloudVisit Connect, http://www.cloudvisittm.com/telemedicine-plans/cloudvisit-connect/

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2498222

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:

CloudVisit Telemedicine
Daniel Gilbert
CEO, President, and Founder
3182 Route 9, Suite 107A
Cold Spring, New York 10516
Phone: 888-503-3009
http://www.cloudvisittm.com/telepsychiatry-company-contact/

Google+ https://plus.google.com/u/0/b/115840735003809004779/115840735003809004779/posts

Facebook: www.facebook.com/CloudVisit

Twitter @CloudVisit

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.